Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway

Area of Science:

• Cellular Biology
• Molecular Pharmacology
• Toxicology

Background:

• Palytoxin inhibits epidermal growth factor (EGF) binding via a protein kinase C-independent pathway.
• The precise mechanism of palytoxin's action on EGF receptors remains unclear.

Purpose of the Study:

• To elucidate the mechanism underlying palytoxin's inhibition of EGF receptor binding in Swiss 3T3 cells.
• To investigate the roles of calcium and sodium ions in palytoxin's activity.

Main Methods:

• Assessing EGF binding in the presence and absence of calcium.
• Utilizing aequorin to monitor intracellular calcium levels.
• Evaluating palytoxin's effect on EGF binding with various extracellular cations (sodium, lithium, potassium, cesium).
• Measuring sodium influx induced by palytoxin.
• Comparing palytoxin's effects with the sodium ionophore monensin.

Main Results:

• Palytoxin inhibits EGF binding independently of extracellular calcium.
• Palytoxin-induced inhibition of EGF binding is dependent on extracellular sodium.
• Palytoxin stimulates rapid, dose-dependent sodium influx.
• Lithium can substitute for sodium, but potassium and cesium cannot.
• Monensin mimics palytoxin's inhibition of EGF binding.

Conclusions:

• Palytoxin down-modulates EGF receptors through a novel mechanism.
• This mechanism involves the activation or formation of a sodium pump or channel.
• The findings highlight a unique ion-dependent pathway for receptor modulation by palytoxin.